Sponsor Pipeline

Kang Stem Biotech Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-10 NCT07754175 A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy… Recruiting
Active Trials by Phase
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07754175 A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy… Knee Osteoarthritis Recruiting
NCT04730024 Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple… Atopic Dermatitis Not Yet Recruiting
NCT06013306 Long-Term Follow-up Study of Subjects With Knee Osteoarthritis Who Had Administered… Knee Osteoarthritis Not Yet Recruiting
NCT07582237 Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106) Dermatitis, Atopic Active, Not Recruiting
Disease Areas
Atopic Dermatitis (1)
Get alerts when Kang Stem Biotech Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free